News + Filings Transactions
|
BEN-MAIMON CAROLE
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | Larimar Therapeutics, Inc. | ZFGN | Purchase | Common Stock | 5k | $3.71 | $18.5k | | 05/17/2023 |
| 09/16/2022 | Larimar Therapeutics, Inc. | ZFGN | Purchase | Common Stock | 31.7k | $3.15 | $100k | | 09/16/2022 |
| 05/10/2022 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 40k | $2.92 | $116.8k | | 05/10/2022 |
| 01/18/2022 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 182k | $8.75 | $1.6M | | 01/18/2022 |
| 07/21/2021 | Teligent, Inc. | TLGT | Grant | Restricted Stock Units | 150k | $0.00 | $0 | | 07/21/2021 |
| 01/19/2021 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 106.7k | $19.61 | $2.1M | | 01/19/2021 |
| 09/29/2020 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (right to buy) | 411.4k | $11.90 | $4.9M | | 09/29/2020 |
| 06/26/2020 | Larimar Therapeutics, Inc. | ZFGN | Other (acquisition) | Common Stock | 25.1k | $0.00 | $0 | | 06/26/2020 |
| 01/02/2020 | Teligent, Inc. | TLGT | Grant | Stock Option | 20k | $0.42 | $8.3k | | 01/02/2020 |
| 07/01/2019 | Teligent, Inc. | TLGT | Grant | | 15.4k | $0.65 | $10k | | 07/01/2019 |
| 05/30/2019 | Teligent, Inc. | TLGT | Purchase | Common Stock | 10k | $0.59 | $5.9k | | 05/30/2019 |
| 05/13/2019 | Teligent, Inc. | TLGT | Grant | | 10.9k | $0.86 | $9.4k | | 05/13/2019 |
| 05/13/2019 | Teligent, Inc. | TLGT | Grant | | 11.6k | $0.86 | $10k | | 05/13/2019 |
| 01/02/2019 | Teligent, Inc. | TLGT | Grant | Stock Option | 20k | $1.32 | $26.4k | | 01/02/2019 |
| 01/02/2018 | Teligent, Inc. | TLGT | Grant | Stock Option | 20k | $3.85 | $77k | | 01/02/2018 |
| 11/13/2017 | Teligent, Inc. | TLGT | Purchase | Common Stock | 3.6k | $3.48 | $12.5k | | 11/13/2017 |
| 11/13/2017 | Teligent, Inc. | TLGT | Purchase | Common Stock | 1.4k | $3.48 | $4.9k | | 11/13/2017 |
| 01/03/2017 | Teligent, Inc. | TLGT | Grant | Stock Option | 20k | $7.05 | $141k | | 01/03/2017 |
| 10/25/2013 | IMPAX LABORATORIES INC | IPXL | Exercise | Employee Stock Option (Right-To-Buy) | 6.7k | $18.93 | $127.5k | | 10/25/2013 |
| 10/10/2013 | IMPAX LABORATORIES INC | IPXL | Exercise | Employee Stock Option (Right-To-Buy) | 5.3k | $18.93 | $100k | | 10/10/2013 |
| 10/28/2012 | IMPAX LABORATORIES INC | IPXL | Payment of Exercise | Common Stock | 1.8k | $24.34 | $44.7k | | 10/28/2012 |
| 10/28/2011 | IMPAX LABORATORIES INC | IPXL | Grant | Common Stock | 24k | $0.00 | $0 | | 10/28/2011 |
| 10/28/2011 | IMPAX LABORATORIES INC | IPXL | Grant | Employee Stock Option (Right-to-Purchase) | 75k | $18.93 | $1.4M | | 10/28/2011 |
|